According to filings with the U.S. Securities and Exchange Commission, Apprentice FS is raising $8,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Angelo Stracquatanio played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Apprentice FS
Apprentices disruptive technology helps pharma manufacturers get medicine to patients faster by providing one platform to turn molecules into medicine. The company’s intelligent cloud platform integrates augmented reality, voice recognition, and artificial intelligence into wearable, mobile, and desktop devices to offer a virtual collaboration application and a robust manufacturing and lab execution system that reduce human error and inefficiency in the drug production process. Learn how 15 of the top 20 US Pharma companies use Apprentice to accelerate high-quality production of drugs for diseases of all types, from COVID to cancer.

To learn more about Apprentice FS, visit http://www.apprentice.io/

Contact:
Angelo Stracquatanio, Chief Executive Officer
201-819-1575
https://www.linkedin.com/in/astracquatanio/

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.